Resetting the immune system with immunoablation and autologous haematopoietic stem cell transplantation in autoimmune diseases

Clinical and Experimental Rheumatology

Volumn 34, Issue , 2016, Pages 53-57

  Alexander, Tobias ^a,b   Arnold, Renate ^a   Hiepe, Falk ^a,b   Radbruch, Andreas ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

Autoimmune diseases; Autologous haematopoietic stem cells transplantation (ASCT); Immune reconstitution; Immune reset; Stem cell transplantation

Indexed keywords

ALEMTUZUMAB; ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; MONOCLONAL ANTIBODY; RITUXIMAB; T LYMPHOCYTE RECEPTOR; THYMOCYTE ANTIBODY; AUTOANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADOPTIVE TRANSFER; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CD34 SELECTION; CD4+ T LYMPHOCYTE; HUMAN; IMMUNOABLATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTOPENIA; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T CELL DEPLETION; ADVERSE EFFECTS; ANIMAL; AUTOIMMUNE DISEASES; AUTOIMMUNITY; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; PHENOTYPE; REGULATORY T LYMPHOCYTE; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; PHENOTYPE; REMISSION INDUCTION; SELF TOLERANCE; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84984819107     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. HIEPE F, DORNER T, HAUSER AE, HOYER BF, MEI H, RADBRUCH A: Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol 2011; 7: 170-8.
2. HOYER BF, MOSER K, HAUSER AE et al.: Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 204; 199: 1577-84.
3. MUMTAZ IM, HOYER BF, PANNE D et al.: Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity. J Autoimmun 2012; 39: 180-8.
4. CHENG Q, MUMTAZ IM, KHODADADI L, RADBRUCH A, HOYER BF, HIEPE F: Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis. Ann Rheum Dis 2013;72: 2011-7.
5. SYKES M, NIKOLIC B: Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005; 435: 620-7.
6. COUZIN-FRANKEL J: Immunology. Replacing an immune system gone haywire. Science 2010; 327: 772-4.
7. van BEKKUM DW, BOHRE EP, HOUBEN PF, KNAAN-SHANZER S: Regression of adjuvant- induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci USA 1989; 86: 10090-4.
8. IKEHARA S: Stem cell transplantation for autoimmune diseases: what can we learn from experimental models? Autoimmunity 2008; 41: 563-9.
9. FARGE D, LABOPIN M, TYNDALL A et al.: Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 2010; 95: 284-92.
10. ALCHI B, JAYNE D, LABOPIN M et al.: Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry. Lupus 2013; 22: 245-53.
11. MANCARDI GL, SORMANI MP, GUALANDI F et al.: Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial. Neurology 2015; 84: 981-8.
12. BURT RK, VERDA L, OYAMA Y, STATKUTE L, SLAVIN S: Non-myeloablative stem cell transplantation for autoimmune diseases. Springer Semin Immunopathol 2004; 26: 57-69.
13. van LAAR JM, FARGE D, SONT JK et al.: Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 2014; 311: 2490-8.
14. HAWKEY CJ, ALLEZ M, CLARK MM et al.: Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial. JAMA 2015; 314: 2524-34.
15. LOONEY RJ, ANOLIK JH, CAMPBELL D et al.: B cell depletion as a novel treatment for sys- temic lupus erythematosus: a phase I/II doseescalation trial of rituximab. Arthritis Rheum 2004; 50: 2580-9.
16. ALEXANDER T, THIEL A, ROSEN O et al.: Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood 2009; 113: 214-23.
17. ZAND MS, VO T, PELLEGRIN T et al.: Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. Blood 2006; 107: 2895-903.
18. MOORE J, BROOKS P, MILLIKEN S et al.: A pilot randomized trial comparing CD34- selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002; 46: 2301-9.
19. FARGE D, HENEGAR C, CARMAGNAT M et al.: Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum 2005; 52: 1555-63.
20. GUNTHER J, RADEMACHER J, van LAAR JM, SIEGERT E, RIEMEKASTEN G: Functional autoantibodies in systemic sclerosis. Semin Immunopathol 2015; 37: 529-42.
21. SUN W, POPAT U, HUTTON G et al.: Characteristics of T-cell receptor repertoire and myelinreactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain 2004; 127: 996-1008.
22. ABRAHAMSSON SV, ANGELINI DF, DUBINSKY AN et al.: Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. Brain 2013; 136: 2888-903.
23. TOKOYODA K, ZEHENTMEIER S, HEGAZY AN et al.: Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity 2009; 30: 721-30m.
24. BRINKMAN DM, JOL-van der ZIJDE CM, ten DAM MM et al.: Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines. J Clin Immunol 2007; 27: 647-58.
25. GUILLAUME T, RUBINSTEIN DB, SYMANN M: Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471-90.
26. KONYA V, MJOSBERG J: Innate lymphoid cells in graft-versus-host disease. Am J Transplant 2015; 15: 2795-801.
27. ABRAHAMSSON S, MURARO PA: Immune reeducation following autologous hematopoietic stem cell transplantation. Autoimmunity 2008; 41: 577-84.
28. MURARO PA, ROBINS H, MALHOTRA S et al.: T cell repertoire following autologous stem cell transplantation for multiple sclerosis. J Clin Invest 2014; 124: 1168-72.
29. MURARO PA, DOUEK DC, PACKER A et al.: Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201: 805-16.
30. JAMESON SC: Maintaining the norm: T-cell homeostasis. Nat Rev Immunol 2002; 2: 547- 56.
31. KING C, ILIC A, KOELSCH K, SARVETNICK N: Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004; 117: 265-77.
32. ZHANG L, BERTUCCI AM, RAMSEY-GOLDMAN R, BURT RK, DATTA SK: Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus. J Immunol 2009; 183: 6346-58.
33. THIEL A, ALEXANDER T, SCHMIDT CA et al.: Direct assessment of thymic reactivation after autologous stem cell transplantation. Acta Haematol 2008; 119: 22-7.
34. KIMMIG S, PRZYBYLSKI GK, SCHMIDT CA et al.: Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002; 195: 789-94.
35. DOUEK DC, McFARLAND RD, KEISER PH et al.: Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396: 690-5.
36. de KLEER I, VASTERT B, KLEIN M et al.: Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006; 107: 1696-702.
37. ALEXANDER T, SATTLER A, TEMPLIN L et al.: Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus. Ann Rheum Dis 2013; 72, 1549-58.
38. THORNTON AM1, KORTY PE, TRAN DQ et al.: Expression of Helios, an Ikaros transcription factor family member, differentiates thymicderived from peripherally induced Foxp3+ T regulatory cells. J Immunol 2010; 184: 3433- 41.
39. DELEMARRE EM, van den BROEK T, MIJNHEER G et al.: Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells. Blood 2016; 127: 91-101.
40. DORNER T, JACOBI AM, LEE J, LIPSKY PE: Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J Immunol Methods 2011; 363: 187-97.
41. MENSEN A, OCHS C, STROUX A et al.: Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation. J Transl Med 2013; 11: 188.
42. ALEXANDER T, BONDANZA A, MURARO PA et al.: SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking. Bone Marrow Transplant 2015; 50: 173-80.
43. RADBRUCH A, MUEHLINGHAUS G, LUGER EO et al.: Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006; 6: 741-50.